1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Microbiome Therapeutics Market
2.2. Global Microbiome Therapeutics Market, By Type, 2023 (US$ Million)
2.3. Global Microbiome Therapeutics Market, By Application, 2023 (US$ Million)
2.4. Global Microbiome Therapeutics Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Microbiome Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Microbiome Therapeutics Market Vendors
3.2. Strategies Adopted by Microbiome Therapeutics Market Vendors
3.3. Key Industry Strategies
4. Microbiome Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Microbiome Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Fecal Microbiota Transplantation (FMT)
5.3.2. Microbiome Drugs

6. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. C. difficile
6.3.2. Crohn’s disease
6.3.3. Inflammatory Bowel Disease
6.3.4. Diabetes
6.3.5. Others


7. North America Microbiome Therapeutics Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
7.3. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
7.4.Microbiome Therapeutics Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
7.4.1.1.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
7.4.1.2.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
7.4.1.3.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)

8. UK and European Union Microbiome Therapeutics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
8.3. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.Microbiome Therapeutics Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
8.4.1.1.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
8.4.1.2.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
8.4.1.3.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
8.4.1.4.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
8.4.1.5.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
8.4.1.6.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)

9. Asia Pacific Microbiome Therapeutics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
9.3. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.Microbiome Therapeutics Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
9.4.1.1.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
9.4.1.2.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
9.4.1.3.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
9.4.1.4.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
9.4.1.5.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
9.4.1.6.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)

10. Latin America Microbiome Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
10.3. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
10.4.Microbiome Therapeutics Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
10.4.1.1.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
10.4.1.2.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
10.4.1.3.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)

11. Middle East and Africa Microbiome Therapeutics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
11.3. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
11.4.Microbiome Therapeutics Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
11.4.1.1.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
11.4.1.2.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Microbiome Therapeutics Market: By Type, 2022-2032, USD (Million)
11.4.1.3.2. Microbiome Therapeutics Market: By Application, 2022-2032, USD (Million)

12. Company Profile
12.1. OpenBiome
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Seres Therapeutics Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. 4D Pharma plc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Locus Biosciences, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Enterome SA
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Finch Therapeutics Group, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Intralytix, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Microbiotica
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Second Genome
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Rebiotix Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Vedanta Bioscience, Inc.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Other Notable Players
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives